Tag: Phase 2 study

November 25, 2019

CymaBay Therapeutics Stops Clinical Development of Seladelpar

The company announced it is terminating a Phase 2b study, a Phase 2 study and putting on hold seladelpar in...
November 12, 2019

Aptinyx Begins Two Phase 2 Studies of NYX-2925

The company is evaluating its NYX-2925 treatment in painful diabetic peripheral neuropathy and fibromyalgia.
April 3, 2019

BELLUS Health Receives Clearance of U.S. IND for BLU-5937 Phase 2 Study in Chronic Cough Patients

BELLUS Health ((TSX:BLU) has announced that the US Food and Drug Administration (FDA) has accepted Bellus’ investigational new drug (IND)...
April 2, 2019

NewLink Genetics Presents Phase 2 Results for NLG207 in Ovarian Cancer at AACR 2019

NewLink Genetics (NASDAQ:NLNK) has announced results from its Phase 2 study of NLG207, a nanoparticle of the topoisomerase 1 inhibitor...
December 4, 2018

Apellis Pharmaceuticals Presents New Data from Ongoing APL-2 Phase 2 Study

Apellis Pharmaceuticals (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition...
May 8, 2018

Zynerba Pharmaceuticals Reports First Quarter 2018 Financial Results and Operational Highlights

Zynerba Pharmaceuticals (NASDAQ:ZYNE), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments for rare...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.